These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38571566)

  • 41. Extending the phenotypes associated with DICER1 mutations.
    Foulkes WD; Bahubeshi A; Hamel N; Pasini B; Asioli S; Baynam G; Choong CS; Charles A; Frieder RP; Dishop MK; Graf N; Ekim M; Bouron-Dal Soglio D; Arseneau J; Young RH; Sabbaghian N; Srivastava A; Tischkowitz MD; Priest JR
    Hum Mutat; 2011 Dec; 32(12):1381-4. PubMed ID: 21882293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ovarian Sertoli-Leydig Cell Tumor, Multinodular Goiter, Cystic Nephromas and
    Ni Y; Zhou X; Wu L; Wu P; Liu Y; Li Y; Cai L; Fu X; Zhang C
    Pharmgenomics Pers Med; 2021; 14():947-953. PubMed ID: 34377011
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Recurrent gynandroblastoma of the ovary with germline
    Mercier AM; Zorn KK; Quick CM; Huffman LB
    Gynecol Oncol Rep; 2021 Aug; 37():100806. PubMed ID: 34169133
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ovarian Sertoli-Leydig tumor: A tricky tumor case report.
    Khalloufi C; Joudar I; Kanas A; Benhessou M; Ennachit M; El Kerroumi M
    Int J Surg Case Rep; 2023 Apr; 105():108043. PubMed ID: 36989630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome.
    Slade I; Bacchelli C; Davies H; Murray A; Abbaszadeh F; Hanks S; Barfoot R; Burke A; Chisholm J; Hewitt M; Jenkinson H; King D; Morland B; Pizer B; Prescott K; Saggar A; Side L; Traunecker H; Vaidya S; Ward P; Futreal PA; Vujanic G; Nicholson AG; Sebire N; Turnbull C; Priest JR; Pritchard-Jones K; Houlston R; Stiller C; Stratton MR; Douglas J; Rahman N
    J Med Genet; 2011 Apr; 48(4):273-8. PubMed ID: 21266384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Moderately differentiated Sertoli-Leydig cell tumor of ovary with associated mucinous carcinoma and carcinoid-A case report and review of literature.
    Ravichandaran A; Lakshmanan A; Kurian A; Prasad S
    Indian J Pathol Microbiol; 2021; 64(3):528-531. PubMed ID: 34341265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sertoli-Leydig cell tumor: a clinicopathological analysis in a comprehensive, national cohort.
    Bekker P; Miland-Samuelsen AR; Smerdel MP; Schnack TH; Lauszus FF; Karstensen SH
    Int J Gynecol Cancer; 2023 Dec; 33(12):1921-1927. PubMed ID: 37907261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Testicular Neoplasms With Sex Cord and Stromal Components Harbor a Recurrent Pattern of Chromosomal Gains.
    Acosta AM; Sholl LM; Maclean F; Kao CS; Ulbright TM
    Mod Pathol; 2024 Jan; 37(1):100368. PubMed ID: 37871653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DICER1 Mutation in Recurrent Ovarian Sertoli-Leydig Cell Tumor: A Case Report.
    Liu S; Pokoradi AJ; Soboleski D; Childs T; Agrawal A
    J Pediatr Adolesc Gynecol; 2023 Apr; 36(2):107-111. PubMed ID: 36402443
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs.
    McCluggage WG; Rivera B; Chong AS; Clarke BA; Schultz KAP; Dehner LP; Tchrakian N; Apellaniz-Ruiz M; Gilks CB; Kommoss F; Stewart CJR; Foulkes WD
    Am J Surg Pathol; 2023 Apr; 47(4):490-496. PubMed ID: 36583307
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mucinous adenocarcinoma as heterologous element in intermediately differentiated Sertoli-Leydig cell tumor of the ovary.
    Virk R; Lu D
    Pathol Res Pract; 2010 Jul; 206(7):489-92. PubMed ID: 19674851
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A novel DICER1 mutation identified in a female with ovarian Sertoli-Leydig cell tumor and multinodular goiter: a case report.
    Rossing M; Gerdes AM; Juul A; Rechnitzer C; Rudnicki M; Nielsen FC; Vo Hansen T
    J Med Case Rep; 2014 Apr; 8():112. PubMed ID: 24708902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
    Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
    N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Familial multinodular goiter and Sertoli-Leydig cell tumors associated with a large intragenic in-frame
    Apellaniz-Ruiz M; de Kock L; Sabbaghian N; Guaraldi F; Ghizzoni L; Beccuti G; Foulkes WD
    Eur J Endocrinol; 2018 Feb; 178(2):K11-K19. PubMed ID: 29187512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Testicular Sertoli cell tumour and potentially testicular Leydig cell tumour are features of
    Golmard L; Vasta LM; Duflos V; Corsini C; Dubois d'Enghien C; McMaster ML; Harney LA; Carr AG; Ling A; Dijoud F; Gauthier A; Miettinen M; Cost NG; Gauthier-Villars M; Orbach D; Irtan S; Haouy S; Schultz KA; Stoppa-Lyonnet D; Coupier I; Stewart DR; Sirvent N
    J Med Genet; 2022 Apr; 59(4):346-350. PubMed ID: 33782093
    [No Abstract]   [Full Text] [Related]  

  • 56. Germline and somatic DICER1 mutations in familial and sporadic liver tumors.
    Caruso S; Calderaro J; Letouzé E; Nault JC; Couchy G; Boulai A; Luciani A; Zafrani ES; Bioulac-Sage P; Seror O; Imbeaud S; Zucman-Rossi J
    J Hepatol; 2017 Apr; 66(4):734-742. PubMed ID: 28012864
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DICER1 hot-spot mutations in ovarian gynandroblastoma.
    Wang Y; Karnezis AN; Magrill J; Tessier-Cloutier B; Lum A; Senz J; Gilks CB; McCluggage WG; Huntsman DG; Kommoss F
    Histopathology; 2018 Aug; 73(2):306-313. PubMed ID: 29660837
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of the DICER1 hotspot mutation alongside immunohistochemical analysis may provide a better diagnostic measure for ovarian Sertoli-Leydig cell tumors.
    Zhang X; Shen D; Wang Y
    Pathol Res Pract; 2018 Sep; 214(9):1370-1375. PubMed ID: 30072170
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Congenital pleuropulmonary blastoma in a newborn with a variant of uncertain significance in DICER1 evaluated by RNA-sequencing.
    Lyle ANJ; Ohlsen TJD; Miller DE; Brown G; Waligorski N; Stark R; Taylor MR; Puia-Dumitrescu M
    Matern Health Neonatol Perinatol; 2023 Mar; 9(1):4. PubMed ID: 36922881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histone H3 trimethylation on lysine 27 immunostaining pattern in
    Alturkustani M; Yang B; Bockoven C; Mahabir R; Shillingford N; Schmidt RJ; Zhou S; Warren M; Parham DM; Pawel B; Wang LL
    Transl Pediatr; 2024 Apr; 13(4):624-633. PubMed ID: 38715664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.